期刊文献+

药学知识的横向思维在药物治疗学教学中的应用

Application in pharmacotherapy teaching with lateral thinking of pharmaceutical knowledge
原文传递
导出
摘要 药学知识一般按照化学结构、药效学、药动学、药物不良反应、相互作用、适应证、禁忌证和用法用量等纵向顺序进行教学,而临床上针对复杂多变的病情和个体化特征的患者,往往需要比较一类药与另一类药或一个药与另一个药之间的差别,即通过药学知识的横向思维,评估药物治疗的得失利弊,扬长避短、趋利避害,作出合理决策。为此我们在药物治疗学的教学过程中开展了药学知识横向思维的训练,以加深学生或学员对药学知识理解的深度与广度,为参加治疗团队和参与药物治疗的决策打下扎实的基础。 Traditional drug therapy education was conducted in according to following vertical order, chemical structure, pharmacodynamics, pharmacokinetics, adverse drug reactions, drug interactions, drug indications, drug con- traindications, dosage and other instruction, while patients' complex clinical condition need doctor have more horizontal drug comparison between drug category and drug detail. Pharmaceutical knowledge about lateral thinking could help doc- tor evaluate advantages and disadvantages in drug therapy and make reasonable decisions, so drug therapeutic applicated "lateral thinking" could deepen medical students' learning of drug therapy in the depth and breadth. When they partici- pate in the team, they will have a solid foundation in decision of medical treatment.
出处 《中国临床药学杂志》 CAS 2015年第2期116-118,共3页 Chinese Journal of Clinical Pharmacy
关键词 药物治疗 药学教学 横向思维 drug therapy pharmacy education lateral thinking
  • 相关文献

参考文献6

二级参考文献91

  • 1王海鹰,荆志成,李崇剑,王建德,徐希奇,邓可武.肺栓塞患者华法林抵抗现象一例及文献回顾[J].中华心血管病杂志,2004,32(11):1039-1040. 被引量:6
  • 2张海英,张斌,李玉珍.华法林的相互作用及其安全应用[J].药物不良反应杂志,2007,9(2):112-116. 被引量:65
  • 3国家药典委员会.中华人民共和国药典临床用药须知(化学药和生物制品卷)[S].北京:人民卫生出版社,2005:491.
  • 4Joy TR,Hegele RA.Narrative review:statin-.related myopathy[J].Ann Intern Med,2009,150(12),858-868.
  • 5Armitage J,Bowman L,Collins R,et al.Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people[J].BMC Clin Pharmacol,2009,9,6.
  • 6Bruckert E,Hayem G,Dejager S,et al.Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemis patients-The PRIMO Study[J].Cardiovasc Drugs and Ther,2005,19(6):403-414.
  • 7Sewright KA,Clarkson PM,Thompson PD Statin myopathy:incidence,risk factors,and pathophysiology[J].Curr Ateheroscler Rep,2007,9(5):389-396.
  • 8Yu JG.Sewright K,Hubal MJ,et al.Investigation of gene expression in C2C12 myotubes following simvastatin application and mechanical strain[J].Journal of Atherosclerosis and Thrombosis,2009,16,21-29.
  • 9Hanai J,Cao P,Tanksale P,et al.The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity[J].The Journal of Clinical Investigation,2007,117(12):3940-3951.
  • 10Link E,Parish S,Armitage J,et al.SLCOIBI variants and statin-induced myopathy-a genomewide study[J].N Engl J Med,2008,359(8):789-799.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部